Valuation Daiichi Sankyo Company, Limited

Equities

4568

JP3475350009

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:12:45 11/12/2025 GMT			5-day change	1st Jan Change
3,370.00 ^JPY	-1.32%		-5.63%	-22.54%

02:10am	Japan's Corporate Unwind Fuels Record Year for Block Trades	MT
12-09	Astrazeneca, Daiichi Sankyo Begin Phase 3 Trial of Enhertu Combination in Ovarian Cancer	MT

Company Valuation: Daiichi Sankyo Company, Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,179,276	5,136,821	9,244,546	9,159,669	6,590,893	6,321,333	-	-
Change	-	-16.87%	79.97%	-0.92%	-28.04%	-4.09%	-	-
Enterprise Value (EV) ¹	5,538,193	4,456,437	8,995,480	8,614,202	6,052,387	5,690,889	5,632,904	5,549,799
Change	-	-19.53%	101.85%	-4.24%	-29.74%	-5.97%	-1.02%	-1.48%
P/E ratio	82.3x	76.7x	84.7x	45.6x	22.5x	20.2x	16.7x	14.1x
PBR	4.86x	3.8x	6.39x	5.43x	4.1x	3.57x	3.09x	2.71x
PEG	-	-7.1x	1.3x	0.5x	0.5x	2.4x	0.8x	0.8x
Capitalization / Revenue	6.42x	4.92x	7.23x	5.72x	3.49x	3.01x	2.7x	2.41x
EV / Revenue	5.75x	4.26x	7.04x	5.38x	3.21x	2.71x	2.4x	2.12x
EV / EBITDA	45.7x	33.9x	47.8x	31.8x	15.1x	13.4x	10.9x	9.63x
EV / EBIT	86.8x	61x	74.6x	40.7x	18.2x	15.6x	12.7x	10.4x
EV / FCF	36.2x	58.3x	-62.8x	27.2x	-97x	14.4x	19.2x	15.6x
FCF Yield	2.76%	1.72%	-1.59%	3.68%	-1.03%	6.94%	5.21%	6.42%
Dividend per Share ²	27	27	30	50	60	76.15	84.3	94.24
Rate of return	0.84%	1.01%	0.62%	1.05%	1.71%	2.23%	2.47%	2.76%
EPS ²	39.17	34.94	56.96	104.7	156	169.1	205	241.5
Distribution rate	68.9%	77.3%	52.7%	47.8%	38.5%	45%	41.1%	39%
Net sales ¹	962,516	1,044,900	1,278,478	1,601,700	1,886,256	2,097,211	2,344,239	2,619,063
EBITDA ¹	121,177	131,270	188,369	271,234	400,574	425,302	516,312	576,059
EBIT ¹	63,795	73,000	120,580	211,600	331,925	363,766	444,423	531,863
Net income ¹	75,958	67,000	109,188	200,700	295,756	310,717	372,908	442,700
Net Debt ¹	-641,083	-680,384	-249,066	-545,467	-538,506	-630,443	-688,429	-771,534
Reference price ²	3,225.00	2,680.00	4,822.00	4,777.00	3,511.00	3,415.00	3,415.00	3,415.00
Nbr of stocks (in thousands)	1,916,055	1,916,724	1,917,160	1,917,452	1,877,212	1,851,049	-	-
Announcement Date	27/04/21	27/04/22	27/04/23	25/04/24	25/04/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DAIICHI SANKYO COMPANY, LIMITED	20.52x	2.76x	13.62x	2.19%	40.43B
ELI LILLY AND COMPANY	42.94x	14.23x	31.57x	0.6%	890B
JOHNSON & JOHNSON	19.08x	5.36x	14.83x	2.58%	498B
ABBVIE INC.	52.09x	7.39x	17.5x	2.93%	398B
ROCHE HOLDING AG	18.3x	4.6x	11.51x	3.13%	343B
ASTRAZENECA PLC	27.25x	5.16x	15.31x	1.78%	279B
NOVARTIS AG	18.3x	4.95x	11.64x	3.08%	252B
MERCK & CO., INC.	12.52x	4.1x	8.77x	3.34%	242B
NOVO NORDISK A/S	12.97x	4.66x	9.65x	3.89%	214B
AMGEN INC.	23.98x	5.88x	10.1x	3.04%	170B
Average	24.79x	5.91x	14.45x	2.66%	332.62B
Weighted average by Cap.	29.36x	7.71x	18.05x	2.28%